Edmond De Rothschild Holding S.A. / BMRN
Edmond De Rothschild Holding S.A.’s Biomarin Pharmaceutical Inc Position
Does Edmond De Rothschild Holding S.A. own Biomarin Pharmaceutical Inc (BMRN)? Yes — 686.0K shares worth $39M (+0.56% of its 13F portfolio) as of Q1 2026, up from 664.5K shares the prior filed quarter.
Position Value
$39M
Q1 2026
Shares
686.0K
% of Portfolio
+0.56%
Quarters Held
21
currently held
Position History BMRN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 686.0K | $39M | +0.56% |
| Q4 2025 | 664.5K | $39M | +0.56% |
| Q3 2025 | 677.4K | $37M | +0.57% |
| Q2 2025 | 649.4K | $36M | +0.57% |
| Q1 2025 | 563.5K | $40M | +0.70% |
| Q4 2024 | 563.5K | $37M | +0.63% |
| Q3 2024 | 413.2K | $29M | +0.47% |
| Q2 2024 | 189.2K | $16M | +0.26% |
| Q1 2024 | 189.2K | $17M | +0.28% |
| Q4 2023 | 219.5K | $21M | +0.38% |
| Q3 2023 | 219.5K | $19M | +0.39% |
| Q2 2023 | 148.3K | $13M | +0.25% |
| Q1 2023 | 89.8K | $9M | +0.20% |
| Q4 2022 | 74.8K | $8M | +0.18% |
| Q3 2022 | 85.5K | $7M | +0.19% |
| Q2 2022 | 56.7K | $5M | +0.11% |
| Q1 2022 | 1.3K | $104,000 | 0.00% |
| Q4 2021 | 1.9K | $165,000 | 0.00% |
| Q3 2021 | 2.0K | $155,000 | 0.00% |
| Q2 2021 | 6.8K | $570,000 | +0.01% |
| Q1 2021 | 6.9K | $521,000 | +0.01% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Edmond De Rothschild Holding S.A.’s full portfolio or all institutional holders of BMRN.